Follow The Filings

BWIN Baldwin Insurance Group

Baldwin Insurance Group earnings company data as of 7:06 PM ET 10/30

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS 0.26 — —
Rev $491.8M — —

Insider trades

Open-market buys and sales by BWIN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BWIN insider trades
  • $1M bought by 1 insider
  • $13.3M sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Seth Bala Cohen General Counsel
    Sale
    $300K 15,000 shares at $20.01 52% of stake
    Traded May 14 Filed May 15
  2. Elizabeth Krystyn Insider
    Sale
    $4.3M 202,000 shares at $21.19 100% of stake
    Traded May 6–7 Filed May 8
  3. Elizabeth Krystyn Insider
    Sale
    $2.5M 119,987 shares at $21.25 100% of stake
    Traded Mar 6 Filed Mar 6
  4. Paul Eugene Sparks Director
    Buy
    $1M 44,200 shares at $22.66 +4.6% to stake
    Traded Mar 2–3 Filed Mar 4
  5. James Morgan Roche See Remarks
    Sale
    $5.7M 240,000 shares at $23.93 85% of stake
    Traded Dec 11–15 Filed Dec 15, 2025
  6. James Morgan Roche See Remarks
    Sale
    $376K 15,000 shares at $25.08 26% of stake
    Traded Dec 5, 2025 Filed Dec 9, 2025

Also filed in the last 12 months, not counted as buying or selling: 52 stock grants, 31 share withholdings for taxes, 12 conversions, 3 other transactions, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
8-K 2.02,7.01,9.01
8-K 9.01
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 5.02
DEFA14A FORM DEFA14A
DEFA14A FORM DEFA14A
DEFA14A FORM DEFA14A
DEFA14A FORM DEFA14A
8-K 1.01,7.01,9.01
8-K 2.02,9.01
10-Q
8-K 5.02,5.07
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
DEFA14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.